AI Article Synopsis
- There is no effective antiviral therapy or immune-based treatment available for COVID-19 currently.
- The focus is on preventing mild cases from worsening into severe infections.
- The paper proposes nocturnal oxygen therapy as a potential at-home treatment to limit virus replication and boost the immune response, possibly aiding in disease progression prevention.
Article Abstract
There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319633 | PMC |
| http://dx.doi.org/10.1016/j.ijid.2020.06.080 | DOI Listing |
Publication Analysis
Top Keywords
nocturnal oxygen
12
oxygen therapy
12
therapy option
8
therapy
4
option early
4
covid-19
4
early covid-19
4
covid-19 currently
4
currently effective
4
effective antiviral
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!